The Role of Tegafur/Uracil in Pulmonary Malignancy
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 58 (Supplement) , 71-75
- https://doi.org/10.2165/00003495-199958003-00010
Abstract
Tegafur/uracil (UFT®) is an oral fluorinated pyrimidine composed of a combination of uracil and tegafur in a 4: 1 molar ratio. When given on a continuous basis, it yields a fluorouracil area under...Keywords
This publication has 8 references indexed in Scilit:
- Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer.Lung Cancer, 1997
- Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.Journal of Clinical Oncology, 1996
- A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancerCancer, 1995
- [A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion versus orally UFT in plasma of same patients].1993
- [Experimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice].1990
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Report on nationwide pooled data and cohort investigation in UFT phase II studyCancer Chemotherapy and Pharmacology, 1988
- Phase II Study of UFT in Patients With Advanced Non-Small Cell Lung CancerJapanese Journal of Clinical Oncology, 1986